MAR 14, 2016 2:21 PM PDT

Functional Heart Muscle Regenerated Using Human Cells

WRITTEN BY: Julianne Chiaet
A partially recellularized human whole-heart cardiac scaffold, reseeded with human cardiomyocytes derived from induced pluripotent stem cells, being cultured in a bioreactor that delivers a nutrient solution and replicates some of the environmental conditions around a living heart. Researchers have developed functional heart tissue in a lab. Their work can be used to help grow heart tissue patches using the patient’s own cells. 

The Massachusetts General Hospital (MGH) scientists created the tissue using donor hearts stripped of components that would generate an immune response. They additionally used cardiac muscle cells generated from induced pluripotent stem cells. Pluripotent stem cells are cells taken from any tissue (usually the skin or blood) of a person and reengineered to behave like an embryonic stem cell. In this case, the pluripotent stem cells could be taken from a potential recipient. 

"Generating functional cardiac tissue involves meeting several challenges," said biomedical engineer Jacques Guyette, the lead author  of the paper. "These include providing a structural scaffold that is able to support cardiac function, a supply of specialized cardiac cells, and a supportive environment in which cells can repopulate the scaffold to form mature tissue capable of handling complex cardiac functions.”

The researchers grew a scaffold from proteins secreted by the cell to give the tissues shape. They used 73 donor hearts, deemed unfit for transplant, to create the tissue. Using a method invented by team leader Harald Ott in 2008, the scientists stripped living cells out of the donor organs (decellularization). They then repopulated the remaining extracellular matrix scaffold with organ-appropriate cell-types (recellularization). In this recellularization step, messenger RNA was used to regenerate skin cells back to stem cells. The resulting pluripotent stem cells were then programmed to grow cardiac muscle cells.

The organs were then mounted for 14 days in an automated bioreactor system the researchers previously developed. The automated bioreactor system has the ability to support a whole human heart during the recellularization process. 

The researchers’ method led to a high retention of matrix proteins and a structure without cardiac cells. The method also allowed for the preservation of coronary vascular and microvascular structures. 
 

Creating a bioengineered human heart is "most certainly a long-term goal that is several years away," says Guyette. "We are currently working on engineering a functional myocardial patch that could replace cardiac tissue damaged due a heart attack or heart failure."

"Among the next steps [include] improving methods to generate even more cardiac cells - recellularizing a whole heart would take tens of billions, optimizing bioreactor-based culture techniques to improve the maturation and function of engineered cardiac tissue, and electronically integrating regenerated tissue to function within the recipient's heart."

Ott adds that "generating personalized functional myocardium from patient-derived cells is an important step towards novel device-engineering strategies and will potentially enable patient-specific disease modeling and therapeutic discovery. Our team is excited to further develop both of these strategies in future projects."

The research was published on March 11, 2016, in the journal Circulation Research.

Sources: Massechussetts General Hospital press release via EurekAlert!, Circulation Research 
About the Author
  • Julianne (@JuliChiaet) covers health and medicine for LabRoots. Her work has been published in The Daily Beast, Scientific American, and MailOnline. While primarily a science journalist, she has also covered culture and Japanese organized crime. She is the New York Board Representative for the Asian American Journalists Association (AAJA). • To read more of her writing, or to send her a message, go to Jchiaet.com
You May Also Like
JAN 25, 2020
Neuroscience
JAN 25, 2020
Are You Still Working on Your New Year's Resolution?
There are a few cardinal rules when it comes to goal-setting, and you've probably heard them all before. Goals will be successful if they are specific-...
JAN 28, 2020
Neuroscience
JAN 28, 2020
Gut Bacteria Influences Behavior in Young Children
Research now suggests that the presence of different gut bacteria may significantly impact children’s behavior, causing some to act out, and some to...
JAN 28, 2020
Cell & Molecular Biology
JAN 28, 2020
A Rare Genetic Disorder is Effectively Treated With Modified Stem Cells
A clinical trial used stem cell gene therapy to treat a rare genetic disorder called X-CGD. Image credit: UCLA Broad Stem Cell Research Center/Nature Medicine...
FEB 02, 2020
Cell & Molecular Biology
FEB 02, 2020
New T Cell Therapy is a Universal Approach to Target Cancer
For years, researchers have been trying to harness the power of the assassins of the immune system - killer T cells....
FEB 14, 2020
Immunology
FEB 14, 2020
Rewired natural killer cells show promising results in leukemia patients
Natural killer (NK) cells are a subset of white blood cells that are key players in the innate immune system, orchestrating host-rejection responses agains...
FEB 24, 2020
Cancer
FEB 24, 2020
Could NRF2 trigger hepatomegaly?
Research published today in the Journal of Hepatology suggests that the protein responsible for antioxidant defenses in humans may adversely affect th...
Loading Comments...